{"id":7155,"date":"2017-10-31T12:57:05","date_gmt":"2017-10-31T04:57:05","guid":{"rendered":"https:\/\/www.ukm.my\/umbi\/?p=7155"},"modified":"2017-10-31T17:09:03","modified_gmt":"2017-10-31T09:09:03","slug":"speaker-abstract-rcmm-2017-mr-khalil-lawless","status":"publish","type":"post","link":"https:\/\/www.ukm.my\/umbi\/speaker-abstract-rcmm-2017-mr-khalil-lawless\/","title":{"rendered":"Speaker Abstract RCMM 2017: Mr. Kahlil Lawless"},"content":{"rendered":"<p style=\"text-align: justify;\">Illumina Next Generation Sequencing is leading a revolution in oncology testing driven by decreasing costs and increasing ease of use in this groundbreaking technology. Here explore examples of how this technology is being applied in pathology labs and updates to the systems and applications that are enabling it, tumor mutation profiling, and cancer risk assessment.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Illumina Next Generation Sequencing is leading a revolution in oncology testing driven by decreasing costs and increasing ease of use in this groundbreaking technology. Here<a class=\"ut-readmore\" href=\"https:\/\/www.ukm.my\/umbi\/speaker-abstract-rcmm-2017-mr-khalil-lawless\/\"> &#8230;<\/a><\/p>\n","protected":false},"author":1001007,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_members_access_role":[],"_members_access_error":""},"categories":[13],"tags":[],"class_list":["post-7155","post","type-post","status-publish","format-standard","hentry","category-uncategorized-en"],"acf":[],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.1.1 - aioseo.com -->\n\t<meta name=\"description\" content=\"Illumina Next Generation Sequencing is leading a revolution in oncology testing driven by decreasing costs and increasing ease of use in this groundbreaking technology. Here explore examples of how this technology is being applied in pathology labs and updates to the systems and applications that are enabling it, tumor mutation profiling, and cancer risk assessment.\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"UMBI Cohort\"\/>\n\t<meta name=\"google-site-verification\" content=\"4\/-mILlRnoOYbEomkaCvmbsOllUc0HnetF4sgUQM6uwog\" \/>\n\t<meta name=\"keywords\" content=\"uncategorized\" \/>\n\t<link rel=\"canonical\" href=\"https:\/\/www.ukm.my\/umbi\/speaker-abstract-rcmm-2017-mr-khalil-lawless\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.1.1\" \/>\n\t\t<meta property=\"og:locale\" content=\"en_US\" \/>\n\t\t<meta property=\"og:site_name\" content=\"UKM Medical Molecular Biology Institute | Leading Institute in Molecular Medicine\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Speaker Abstract RCMM 2017: Mr. Kahlil Lawless | UKM Medical Molecular Biology Institute\" \/>\n\t\t<meta property=\"og:description\" content=\"Illumina Next Generation Sequencing is leading a revolution in oncology testing driven by decreasing costs and increasing ease of use in this groundbreaking technology. Here explore examples of how this technology is being applied in pathology labs and updates to the systems and applications that are enabling it, tumor mutation profiling, and cancer risk assessment.\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/www.ukm.my\/umbi\/speaker-abstract-rcmm-2017-mr-khalil-lawless\/\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2017-10-31T04:57:05+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2017-10-31T09:09:03+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Speaker Abstract RCMM 2017: Mr. Kahlil Lawless | UKM Medical Molecular Biology Institute\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Illumina Next Generation Sequencing is leading a revolution in oncology testing driven by decreasing costs and increasing ease of use in this groundbreaking technology. Here explore examples of how this technology is being applied in pathology labs and updates to the systems and applications that are enabling it, tumor mutation profiling, and cancer risk assessment.\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.ukm.my\\\/umbi\\\/speaker-abstract-rcmm-2017-mr-khalil-lawless\\\/#article\",\"name\":\"Speaker Abstract RCMM 2017: Mr. Kahlil Lawless | UKM Medical Molecular Biology Institute\",\"headline\":\"Speaker Abstract RCMM 2017: Mr. Kahlil Lawless\",\"author\":{\"@id\":\"https:\\\/\\\/www.ukm.my\\\/umbi\\\/author\\\/umbi-cohortgmail-com\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/www.ukm.my\\\/umbi\\\/#organization\"},\"datePublished\":\"2017-10-31T12:57:05+08:00\",\"dateModified\":\"2017-10-31T17:09:03+08:00\",\"inLanguage\":\"en-US\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.ukm.my\\\/umbi\\\/speaker-abstract-rcmm-2017-mr-khalil-lawless\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ukm.my\\\/umbi\\\/speaker-abstract-rcmm-2017-mr-khalil-lawless\\\/#webpage\"},\"articleSection\":\"Uncategorized\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.ukm.my\\\/umbi\\\/speaker-abstract-rcmm-2017-mr-khalil-lawless\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.ukm.my\\\/umbi#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.ukm.my\\\/umbi\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.ukm.my\\\/umbi\\\/category\\\/uncategorized-en\\\/#listItem\",\"name\":\"Uncategorized\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.ukm.my\\\/umbi\\\/category\\\/uncategorized-en\\\/#listItem\",\"position\":2,\"name\":\"Uncategorized\",\"item\":\"https:\\\/\\\/www.ukm.my\\\/umbi\\\/category\\\/uncategorized-en\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.ukm.my\\\/umbi\\\/speaker-abstract-rcmm-2017-mr-khalil-lawless\\\/#listItem\",\"name\":\"Speaker Abstract RCMM 2017: Mr. Kahlil Lawless\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.ukm.my\\\/umbi#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.ukm.my\\\/umbi\\\/speaker-abstract-rcmm-2017-mr-khalil-lawless\\\/#listItem\",\"position\":3,\"name\":\"Speaker Abstract RCMM 2017: Mr. Kahlil Lawless\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.ukm.my\\\/umbi\\\/category\\\/uncategorized-en\\\/#listItem\",\"name\":\"Uncategorized\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.ukm.my\\\/umbi\\\/#organization\",\"name\":\"UKM Medical Molecular Biology Institute\",\"description\":\"Leading Institute in Molecular Medicine\",\"url\":\"https:\\\/\\\/www.ukm.my\\\/umbi\\\/\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.ukm.my\\\/umbi\\\/author\\\/umbi-cohortgmail-com\\\/#author\",\"url\":\"https:\\\/\\\/www.ukm.my\\\/umbi\\\/author\\\/umbi-cohortgmail-com\\\/\",\"name\":\"UMBI Cohort\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/www.ukm.my\\\/umbi\\\/speaker-abstract-rcmm-2017-mr-khalil-lawless\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b6e8ee481e52b1764075eb2ce2a365e357c56d5179999f8e4a8ead9b87b419a9?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"UMBI Cohort\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.ukm.my\\\/umbi\\\/speaker-abstract-rcmm-2017-mr-khalil-lawless\\\/#webpage\",\"url\":\"https:\\\/\\\/www.ukm.my\\\/umbi\\\/speaker-abstract-rcmm-2017-mr-khalil-lawless\\\/\",\"name\":\"Speaker Abstract RCMM 2017: Mr. Kahlil Lawless | UKM Medical Molecular Biology Institute\",\"description\":\"Illumina Next Generation Sequencing is leading a revolution in oncology testing driven by decreasing costs and increasing ease of use in this groundbreaking technology. Here explore examples of how this technology is being applied in pathology labs and updates to the systems and applications that are enabling it, tumor mutation profiling, and cancer risk assessment.\",\"inLanguage\":\"en-US\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ukm.my\\\/umbi\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.ukm.my\\\/umbi\\\/speaker-abstract-rcmm-2017-mr-khalil-lawless\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/www.ukm.my\\\/umbi\\\/author\\\/umbi-cohortgmail-com\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/www.ukm.my\\\/umbi\\\/author\\\/umbi-cohortgmail-com\\\/#author\"},\"datePublished\":\"2017-10-31T12:57:05+08:00\",\"dateModified\":\"2017-10-31T17:09:03+08:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.ukm.my\\\/umbi\\\/#website\",\"url\":\"https:\\\/\\\/www.ukm.my\\\/umbi\\\/\",\"name\":\"UKM Medical Molecular Biology Institute\",\"alternateName\":\"Institut Biologi Molekul Perubatan UKM\",\"description\":\"Leading Institute in Molecular Medicine\",\"inLanguage\":\"en-US\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.ukm.my\\\/umbi\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"Speaker Abstract RCMM 2017: Mr. Kahlil Lawless | UKM Medical Molecular Biology Institute","description":"Illumina Next Generation Sequencing is leading a revolution in oncology testing driven by decreasing costs and increasing ease of use in this groundbreaking technology. Here explore examples of how this technology is being applied in pathology labs and updates to the systems and applications that are enabling it, tumor mutation profiling, and cancer risk assessment.","canonical_url":"https:\/\/www.ukm.my\/umbi\/speaker-abstract-rcmm-2017-mr-khalil-lawless\/","robots":"max-image-preview:large","keywords":"uncategorized","webmasterTools":{"google-site-verification":"4\/-mILlRnoOYbEomkaCvmbsOllUc0HnetF4sgUQM6uwog","miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.ukm.my\/umbi\/speaker-abstract-rcmm-2017-mr-khalil-lawless\/#article","name":"Speaker Abstract RCMM 2017: Mr. Kahlil Lawless | UKM Medical Molecular Biology Institute","headline":"Speaker Abstract RCMM 2017: Mr. Kahlil Lawless","author":{"@id":"https:\/\/www.ukm.my\/umbi\/author\/umbi-cohortgmail-com\/#author"},"publisher":{"@id":"https:\/\/www.ukm.my\/umbi\/#organization"},"datePublished":"2017-10-31T12:57:05+08:00","dateModified":"2017-10-31T17:09:03+08:00","inLanguage":"en-US","mainEntityOfPage":{"@id":"https:\/\/www.ukm.my\/umbi\/speaker-abstract-rcmm-2017-mr-khalil-lawless\/#webpage"},"isPartOf":{"@id":"https:\/\/www.ukm.my\/umbi\/speaker-abstract-rcmm-2017-mr-khalil-lawless\/#webpage"},"articleSection":"Uncategorized"},{"@type":"BreadcrumbList","@id":"https:\/\/www.ukm.my\/umbi\/speaker-abstract-rcmm-2017-mr-khalil-lawless\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/www.ukm.my\/umbi#listItem","position":1,"name":"Home","item":"https:\/\/www.ukm.my\/umbi","nextItem":{"@type":"ListItem","@id":"https:\/\/www.ukm.my\/umbi\/category\/uncategorized-en\/#listItem","name":"Uncategorized"}},{"@type":"ListItem","@id":"https:\/\/www.ukm.my\/umbi\/category\/uncategorized-en\/#listItem","position":2,"name":"Uncategorized","item":"https:\/\/www.ukm.my\/umbi\/category\/uncategorized-en\/","nextItem":{"@type":"ListItem","@id":"https:\/\/www.ukm.my\/umbi\/speaker-abstract-rcmm-2017-mr-khalil-lawless\/#listItem","name":"Speaker Abstract RCMM 2017: Mr. Kahlil Lawless"},"previousItem":{"@type":"ListItem","@id":"https:\/\/www.ukm.my\/umbi#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/www.ukm.my\/umbi\/speaker-abstract-rcmm-2017-mr-khalil-lawless\/#listItem","position":3,"name":"Speaker Abstract RCMM 2017: Mr. Kahlil Lawless","previousItem":{"@type":"ListItem","@id":"https:\/\/www.ukm.my\/umbi\/category\/uncategorized-en\/#listItem","name":"Uncategorized"}}]},{"@type":"Organization","@id":"https:\/\/www.ukm.my\/umbi\/#organization","name":"UKM Medical Molecular Biology Institute","description":"Leading Institute in Molecular Medicine","url":"https:\/\/www.ukm.my\/umbi\/"},{"@type":"Person","@id":"https:\/\/www.ukm.my\/umbi\/author\/umbi-cohortgmail-com\/#author","url":"https:\/\/www.ukm.my\/umbi\/author\/umbi-cohortgmail-com\/","name":"UMBI Cohort","image":{"@type":"ImageObject","@id":"https:\/\/www.ukm.my\/umbi\/speaker-abstract-rcmm-2017-mr-khalil-lawless\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/b6e8ee481e52b1764075eb2ce2a365e357c56d5179999f8e4a8ead9b87b419a9?s=96&d=mm&r=g","width":96,"height":96,"caption":"UMBI Cohort"}},{"@type":"WebPage","@id":"https:\/\/www.ukm.my\/umbi\/speaker-abstract-rcmm-2017-mr-khalil-lawless\/#webpage","url":"https:\/\/www.ukm.my\/umbi\/speaker-abstract-rcmm-2017-mr-khalil-lawless\/","name":"Speaker Abstract RCMM 2017: Mr. Kahlil Lawless | UKM Medical Molecular Biology Institute","description":"Illumina Next Generation Sequencing is leading a revolution in oncology testing driven by decreasing costs and increasing ease of use in this groundbreaking technology. Here explore examples of how this technology is being applied in pathology labs and updates to the systems and applications that are enabling it, tumor mutation profiling, and cancer risk assessment.","inLanguage":"en-US","isPartOf":{"@id":"https:\/\/www.ukm.my\/umbi\/#website"},"breadcrumb":{"@id":"https:\/\/www.ukm.my\/umbi\/speaker-abstract-rcmm-2017-mr-khalil-lawless\/#breadcrumblist"},"author":{"@id":"https:\/\/www.ukm.my\/umbi\/author\/umbi-cohortgmail-com\/#author"},"creator":{"@id":"https:\/\/www.ukm.my\/umbi\/author\/umbi-cohortgmail-com\/#author"},"datePublished":"2017-10-31T12:57:05+08:00","dateModified":"2017-10-31T17:09:03+08:00"},{"@type":"WebSite","@id":"https:\/\/www.ukm.my\/umbi\/#website","url":"https:\/\/www.ukm.my\/umbi\/","name":"UKM Medical Molecular Biology Institute","alternateName":"Institut Biologi Molekul Perubatan UKM","description":"Leading Institute in Molecular Medicine","inLanguage":"en-US","publisher":{"@id":"https:\/\/www.ukm.my\/umbi\/#organization"}}]},"og:locale":"en_US","og:site_name":"UKM Medical Molecular Biology Institute | Leading Institute in Molecular Medicine","og:type":"article","og:title":"Speaker Abstract RCMM 2017: Mr. Kahlil Lawless | UKM Medical Molecular Biology Institute","og:description":"Illumina Next Generation Sequencing is leading a revolution in oncology testing driven by decreasing costs and increasing ease of use in this groundbreaking technology. Here explore examples of how this technology is being applied in pathology labs and updates to the systems and applications that are enabling it, tumor mutation profiling, and cancer risk assessment.","og:url":"https:\/\/www.ukm.my\/umbi\/speaker-abstract-rcmm-2017-mr-khalil-lawless\/","article:published_time":"2017-10-31T04:57:05+00:00","article:modified_time":"2017-10-31T09:09:03+00:00","twitter:card":"summary","twitter:title":"Speaker Abstract RCMM 2017: Mr. Kahlil Lawless | UKM Medical Molecular Biology Institute","twitter:description":"Illumina Next Generation Sequencing is leading a revolution in oncology testing driven by decreasing costs and increasing ease of use in this groundbreaking technology. Here explore examples of how this technology is being applied in pathology labs and updates to the systems and applications that are enabling it, tumor mutation profiling, and cancer risk assessment."},"aioseo_meta_data":{"post_id":"7155","title":null,"description":null,"keywords":null,"keyphrases":null,"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":null,"og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"","isEnabled":true},"graphs":[]},"schema_type":null,"schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":null,"robots_max_videopreview":null,"robots_max_imagepreview":"large","priority":null,"frequency":null,"location":null,"local_seo":null,"breadcrumb_settings":null,"limit_modified_date":false,"ai":null,"created":"2020-12-21 03:08:08","updated":"2025-06-12 13:14:28","seo_analyzer_scan_date":null,"focus_keyword":null,"additional_keywords":null,"truseo_locale":null},"_links":{"self":[{"href":"https:\/\/www.ukm.my\/umbi\/wp-json\/wp\/v2\/posts\/7155","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ukm.my\/umbi\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ukm.my\/umbi\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ukm.my\/umbi\/wp-json\/wp\/v2\/users\/1001007"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ukm.my\/umbi\/wp-json\/wp\/v2\/comments?post=7155"}],"version-history":[{"count":3,"href":"https:\/\/www.ukm.my\/umbi\/wp-json\/wp\/v2\/posts\/7155\/revisions"}],"predecessor-version":[{"id":7240,"href":"https:\/\/www.ukm.my\/umbi\/wp-json\/wp\/v2\/posts\/7155\/revisions\/7240"}],"wp:attachment":[{"href":"https:\/\/www.ukm.my\/umbi\/wp-json\/wp\/v2\/media?parent=7155"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ukm.my\/umbi\/wp-json\/wp\/v2\/categories?post=7155"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ukm.my\/umbi\/wp-json\/wp\/v2\/tags?post=7155"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}